Literature DB >> 1412656

Ivermectin treatment of loiasis.

J P Chippaux1, J C Ernould, J Gardon, N Gardon-Wendel, F Chandre, N Barberi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1412656     DOI： 10.1016/0035-9203(92)90313-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  4 in total

1.  Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.

Authors:  Michel Boussinesq; Jacques Gardon; Nathalie Gardon-Wendel; Jean-Philippe Chippaux
Journal:  Filaria J       Date:  2003-10-24

2.  Effect of a Single Standard Dose (150-200 μg/kg) of Ivermectin on Loa loa Microfilaremia: Systematic Review and Meta-analysis.

Authors:  Sébastien D Pion; Jules Brice Tchatchueng-Mbougua; Cédric B Chesnais; Joseph Kamgno; Jacques Gardon; Jean-Philippe Chippaux; Stéphane Ranque; Jean-Christophe Ernould; André Garcia; Michel Boussinesq
Journal:  Open Forum Infect Dis       Date:  2019-01-11       Impact factor: 3.835

3.  Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo.

Authors:  Jean-Claude Makenga Bof; Daniel Muteba; Paul Mansiangi; Félicien Ilunga-Ilunga; Yves Coppieters
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-16       Impact factor: 2.483

4.  Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.

Authors:  Samuel Wanji; Winston Patrick Chounna Ndongmo; Fanny Fri Fombad; Jonas Arnaud Kengne-Ouafo; Abdel Jelil Njouendou; Yolande Flore Longang Tchounkeu; Benjamin Koudou; Moses Bockarie; Grace Fobi; Jean Baptiste Roungou; Peter A Enyong
Journal:  PLoS Negl Trop Dis       Date:  2018-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.